New pill aims to shrink bladder tumors before surgery
NCT ID NCT03914794
Summary
This study tested if taking a pill called pemigatinib for 4-6 weeks before standard tumor-removal surgery could help treat recurrent, early-stage bladder cancer. It involved 30 adults whose cancer had returned but was still considered low or intermediate risk. The main goal was to see if the drug could completely eliminate the tumor before surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Associated Medical Professionals Urology
Syracuse, New York, 13210, United States
-
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572, United States
-
Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21205, United States
-
Keystone Urology
Lancaster, Pennsylvania, 17604, United States
-
Midlantic Urology
Bala-Cynwyd, Pennsylvania, 19004, United States
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, 20016, United States
Conditions
Explore the condition pages connected to this study.